USPTO serial 79235070
PLATON
Reviewed by CopyMark Law Group
Reg. 5635338Status 709
- Filing date
- Status date
- Registration date
- Dec 25, 2018
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PLATON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Lebow
Mark Lebow Ladas & Parry1700 Diagonal RoadSuite 505Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Products for medical use, namely, pharmaceutical products for use in oncology, especially oligonucleotides, more particularly in the form of double-stranded DNA acting as a decoy or false signal for proteins, especially enzymes, involved in tumor growth and/or tumor escape, more particularly DNA binding proteins and especially tumor cell DNA repair proteins for treating solid and/or liquid cancers | SECTION 71 - CANCELLED | — |
| 042 | Scientific, medical and pharmaceutical research for the research and identification of new pharmaceutical products limited to these oligonucleotides from a proprietary technology platform or chemo-library; pharmaceutical research and development limited to products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory research limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory analysis limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 11, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 25, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 18, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 18, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 26, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 4, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 4, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 25, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 25, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 9, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 9, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 7, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 19, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 19, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 7, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 7, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 7, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 6, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 6, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 5, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 28, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |